Long-term wind resource assessment for small and medium-scale turbines using operational forecast data and measure-correlate-predict

Output from a state-of-the-art, 4 km resolution, operational forecast model (UK4) was investigated as a source of long-term historical reference data for wind resource assessment. The data were used to implement measure-correlate-predict (MCP) approaches at 37 sites throughout the United Kingdom (UK). The monthly and hourly linear correlation between the UK4-predicted and observed wind speeds indicates that UK4 is capable of representing the wind climate better than the nearby meteorological stations considered. Linear MCP algorithms were implemented at the same sites using reference data from UK4 and nearby meteorological stations to predict the long-term (10-year) wind resource. To obtain robust error statistics, MCP algorithms were applied using onsite measurement periods of 1-12 months initiated at 120 different starting months throughout an 11 year data record. Using linear regression MCP over 12 months, the average percentage errors in the long-term predicted mean wind speed and power density were 3.0% and 7.6% respectively, using UK4, and 2.8% and 7.9% respectively, using nearby meteorological stations. The results indicate that UK4 is highly competitive with nearby meteorological observations as an MCP reference data source. UK4 was also shown to systematically improve MCP predictions at coastal sites due to better representation of local diurnal effects

Allestimento di formulazioni di bleomicina intralesionale per carcinoma spinocellulare in dermatologia chirurgica in un’Unità di Manipolazione Chemioterapici Antiblastici (UMaCA).

OBIETTIVO DELLA RICERCA Confermata l’efficacia di bleomicina intralesionale da un’analisi della letteratura scientifica, il presente studio si è proposto di: - Analizzare il caso clinico di un paziente affetto da carcinoma spinocellulare non eleggibile alle terapie standard per età, condizioni cliniche generali complesse e preferenza del soggetto. - Elaborare uno schema terapeutico per l’applicazione clinica del trattamento intralesionale con bleomicina. - Mettere a punto un’ idonea Procedura di Allestimento della terapia oncologica presso l’Unità di Manipolazione Chemioterapici Antiblastici dell’Azienda Ospedaliero-Universitaria di Parma. - Valutare gli esiti clinici derivanti dalla somministrazione del farmaco. - Analizzare nuovi casi clinici per indagare ulteriormente l’efficacia della terapia intralesionale con bleomicina in campo dermatologico

Epidemiology of neurocysticercosis in Brazil Epidemiologia da neurocisticercose no Brasil

A revision of literature was done with the objective of tracing an epidemiologic profile of neurocysticercosis (NCC) in Brazil. The prevalence was 0.12-9% in autopsies. The frequency was 0.03-7.5% in clinical series and 0.68-5.2% in seroepidemiological studies. The disease corresponds to 0.08-2.5% of admissions to general hospitals. Patient origin was rural in 30-63% of cases. The most involved age range (64-100%) was 11 to 60 years, with a predominance (22-67%) between 21 and 40 years. The male sex was the most affected (51-80%). In the severe forms there was a predominance of urban origin (53-62%) and of the female sex (53-75%). The period of hospitalization ranges from 1 to 254 days and 33 to 50% of patients suffer 1.7 &plusmn; 1.4 admissions. The clinical picture was variable, with a predominance of epileptic syndrome (22-92%) and intracranial hypertension (19-89%). Psychiatric manifestations were associated in 9-23% of patients. Lethality was 0.29% in terms of all diseases in general and 4.8-25.9% in terms of neurologic diseases. The asymptomatic form was detected in 6% of patients in clinical serie and in 48.5% of case from autopsies. The racemose form and ventricular localization also was observed as asymptomatic form. Among the patients with cutaneous cysticercosis 65% of them showed neurologic manifestations.<br>Realizou-se revisão da literatura com o objetivo de tentar delinear um perfil epidemiológico da neurocisticercose no Brasil. A prevalência em necrópsias variou de 0,12-9%. A freqüência, nas casuísticas clínicas foi de 0,03-7,5% e, nos estudos soroepidemiológicos, de 0,68-5,2%. Compreendeu 0,08-2,5% das internações em hospitais gerais. A procedência foi rural em 30-63% dos doentes. Comprometeu mais (64-100%) na faixa etária dos 11 aos 60 anos, predominantemente (22-67%) entre 21 e 40 anos. O sexo masculino foi mais atingido (51-80%). Nas formas graves, houve predomínio da origem urbana (53-62%) e do sexo feminino (53-75%). O período de internação variou de 1 -254 dias, com 33 a 50% dos doentes necessitando 1.7 &plusmn; 1,4 admissões. Houve variabilidade no quadro clínico, predominando síndrome epiléptica (22-92%) e hipertensão intracraniana (19-89%). A presença de manifestações psiquiátricas foi observada em 9-23% dos doentes. A letalidade, frente as doenças em geral, foi de 0,29% e, entre as doenças neurológicas, de 4,8-25,9%. A forma assintomática foi detectada em 6% dos doentes de casuística clínica e em 48,5% dos casos de necrópsia. A forma racemosa e a localização ventricular também se apresentaram de maneira assintomática. Entre os doentes com cisticercose cutânea, 65% apresentavam manifestações neurológicas